U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40
| | | | | | |

U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40

On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…

Anixa Biosciences announced patient dosing of investigational vaccine candidate in first-of-its-kind preventative breast cancer vaccine study
| | | | | |

Anixa Biosciences announced patient dosing of investigational vaccine candidate in first-of-its-kind preventative breast cancer vaccine study

On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…

National Breast and Cervical Cancer Act allowed states federal waivers to spend a greater share of funds on underserved women
| | | | | | |

National Breast and Cervical Cancer Act allowed states federal waivers to spend a greater share of funds on underserved women

On Apr. 20, 2007, the National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 allowed…

FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
| | | |

FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer

On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…